Table 3

Two-dimensional and M-mode echocardiographic left atrial and left ventricular dimensions on ARVC patients, athletes and untrained control subjects

ARVC (n=40)Athletes (n=40)Controls (n=40)ARVC vs athletesARVC vs controlsAthletes vs controls
LA medial–lateral (mm)39.4 (6.7)42.4 (4.3)37 (4.4)0.0050.060.00001
LA superior–inferior (mm)45.9 (8.4)50.3 (4.7)44.5 (5.5)0.0190.3800.00001
Ao (mm)31.9 (3.5)31.5 (3.9)30.5 (3.5)0.6300.070.231
LVEDD (mm)51.4 (4.3)53.5 (4)49.8 (5.3)0.020.140.0007
LVSF (%)38.8 (6.3)40.3 (7.8)39.3 (6.5)0.3470.7270.30
IVS (mm)9.4 (1.1)10 (1.2)9 (1.1)0.0220.100.0002
LVPW (mm)9.1 (1.1)9.6 (1.1)8.9 (1.4)0.040.470.018
LVEDV (ml)61 (8.8)68.1 (10.3)58.5 11)0.0010.2650.0001
LVEF (%)61 (6.5)60.7 (3.6)63.8 (5.8)0.7990.0450.005
RV kinetic abnormalities40000.4350.4351
  • IVS, interventricular septum; LA, left atrium, Ao aortic root; LVEDD, left ventricular end-diastolic diameter; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVPW, left ventricular posterior wall; LVSF, left ventricular fraction shortening.